| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Common Stock | Options Exercise | $0 | +3,936 | +13% | $0.000000 | 35,048 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $32,186 | -1,712 | -4.9% | $18.80 | 33,336 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Options Exercise | $0 | +7,794 | +23% | $0.000000 | 41,130 | 31 Mar 2024 | Direct | |
| transaction | OGN | Common Stock | Tax liability | $43,766 | -2,328 | -5.7% | $18.80 | 38,802 | 31 Mar 2024 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -3,936 | -50% | $0.000000 | 3,937 | 31 Mar 2024 | Common Stock | 3,936 | Direct | F1, F2 | |
| transaction | OGN | Restricted Stock Units | Options Exercise | $0 | -7,794 | -33% | $0.000000 | 15,590 | 31 Mar 2024 | Common Stock | 7,794 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. |
| F2 | The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025. |
| F3 | On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026. |